Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): Comparative protection against lethal challenge in mice

Journal of Virology

Volumn 68, Issue 4, 1994, Pages 2118-2126

  Ghiasi, Homayon ^a,b   Kaiwar, Ravi ^a   Nesburn, Anthony B ^a,b   Slanina, Susan ^a   Wechsler, Steven L ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ANTIBODY TITER; ARTICLE; CELL ACTIVITY; CELL PROTECTION; DELAYED HYPERSENSITIVITY; GENE EXPRESSION; HERPES SIMPLEX VIRUS; KILLER CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; VACCINATION;

EID: 0028349040     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.68.4.2118-2126.1994     Document Type: Article

References (52)

1. Adler, R., J. C. Glorioso, J. Cossman, and M. Levin. 1978. Possible role of Fc receptors on cells infected and transformed by herpes-virus: escape from immune cytolysis. Infect. Immun. 21:442-447.
2. + T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses. J. Virol. 62:2102-2106.
3. Baines, J. D., and B. Roizman. 1993. The UL10 gene of herpes simplex virus 1 encodes a novel viral glycoprotein, gM, which is present in the virion and in the plasma membrane of infected cells. J. Virol. 67:1441-1452.
4. Berman, P., D. Dowbenko, and L. A. Lasky. 1983. Detection of antibodies to herpes simplex virus with a continuous cell line expressing cloned glycoprotein D. Science 222:524-527.
5. Bernstein, D. I., L. S. Loo, and S. Kohl. 1988. Antibody to cloned HSV glycoproteins B and D plus adult human leukocytes protect neonatal mice from lethal HSV infection. Antiviral Res. 10:279-284.
6. Bishop, G. A., G. Kumel, S. A. Schwartz, and J. C. Glorioso. 1986. Specificity of human natural killer cells in limiting dilution culture for determinants of herpes simplex virus type 1 glycoproteins. J. Virol. 57:294-300.
7. Blacklaws, B. A., S. Krishna, A. C. Minson, and A. A. Nash. 1990. Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants. Virology 177:727-736.
8. Bonneau, R., and S. R. Jennings. 1989. Modulation of acute and latent herpes simplex virus infection in C57BL/6 mice by adoptive transfer of immune lymphocytes with cytolytic activity. J. Virol. 63:1480-1484.
9. Chen, S.-H., J. E. Oakes, and R. N. Lausch. 1993. Synergistic anti-HSV effect of tumor necrosis factor alpha and interferon gamma in human corneal fibroblasts is associated with interferon beta induction. Antiviral Res. 22:15-29.
10. Dubin, G., I. Frank, and H. M. Friedman. 1990. Herpes simplex virus type 1 encodes two Fc receptors which have different binding characteristics for monomeric immunoglobulin G (IgG) and IgG complexes. J. Virol. 64:2725-2731.
11. Eis-Hubinger, A. M., D. S. Schmidt, and K. E. Schneweis. 1993. Anti-glycoprotein B monoclonal antibody protects T cell-depleted mice against herpes simplex virus infection by inhibition of virus eplication at the inoculated mucous membranes. J. Gen. Virol. 74:379-385.
12. Friedman, H. M., J. C. Glorioso, G. H. Cohen, J. C. Hastings, S. L. Harris, and R. J. Eisenberg. 1986. Binding of complement component C3b to glycoprotein gC of herpes simplex virus type 1: mapping of gC binding sites and demonstration of conserved C3b binding in low passage clinical isolates. J. Virol. 60:470-475.
13. Fuller, A. O., and P. G. Spear. 1985. Specificities of monoclonal and polyclonal antibodies that inhibit absorption of herpes simplex virus to cells and lack of inhibition by potent neutralizing antibodies. J. Virol. 55:475-482.
14. Fuller, A. O., and P. G. Spear. 1987. Anti-glycoprotein D antibodies that permit absorption but block infection by herpes simplex virus 1 prevent virion cell fusion at the cell surface. Proc. Natl. Acad. Sci. USA 84:5454-5458.
15. Ghiasi, H., R. Kaiwar, A. B. Nesburn, and S. L. Wechsler. 1991. Immunoselection of recombinant baculoviruses expressing high levels of biologically active herpes simplex virus type 1 glycoprotein D. Arch. Virol. 121:163-178.
16. Ghiasi, H., R. Kaiwar, A. B. Nesburn, and S. L. Wechsler. 1992. Baculovirus expressed glycoprotein G of herpes simplex virus type I partially protects vaccinated mice against lethal HSV-1 challenge. Virology 190:233-239.
17. Ghiasi, H., R. Kaiwar, A. B. Nesburn, and S. L. Wechsler. 1992. Expression of glycoprotein B of herpes simplex virus type 1 in insect cells: analysis of its biochemical and immunological properties. Virus Res. 22:25-39.
18. Ghiasi, H., R. Kaiwar, A. B. Nesburn, and S. L. Wechsler. 1992. Expression of herpes simplex virus type 1 glycoprotein I in baculovirus: preliminary biochemical characterization and protection studies. J. Virol. 66:2505-2509.
19. Ghiasi, H., R. Kaiwar, A. B. Nesburn, and S. L. Wechsler. 1992. Baculovirus expressed glycoprotein H (gH) of herpes simplex virus type 1 (HSV-1) induces neutralizing antibody and delayed hypersensitivity responses but does not protect immunized mice against lethal HSV-1 challenge. J. Gen. Virol. 73:719-722.
20. Ghiasi, H., R. Kaiwar, A. B. Nesburn, and S. L. Wechsler. 1992. Baculovirus expressed herpes simplex virus type I glycoprotein C protects mice from lethal HSV-1 infection. Antiviral Res. 18:291-302.
21. Ghiasi, H., R. Kaiwar, A. B. Nesburn, and S. L. Wechsler. 1992. Baculovirus expressed glycoprotein E (gE) of herpes simplex virus type-1 (HSV-1) protects mice against lethal intraperitoneal and lethal ocular HSV-I challenge. Virology 188:469-476.
22. Ghiasi, H., A. B. Nesburn, and S. L. Wechsler. 1991. Cell surface expression of herpes simplex virus type-1 glycoprotein H in recombinant baculovirus infected cells. Virology 185:187-194.
23. Glorioso, J., C. H. Schroder, G. Kumel, M. Szczesiul, and M. Levine. 1984. Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity. J. Virol. 50:805-812.
24. Gompels, U., and A. Minson. 1986. The properties and sequence of glycoprotein H of herpes simplex virus type 1. Virology 153:230-247.
25. Gordon, Y. J., and D. L. Rock. 1984. Co-cultivation versus blot hybridization for the detection of trigeminal ganglionic latency following corneal inoculation with hsv-1 strains of varying TK expression and pathogenicity. Curr. Eye Res. 3:1097-1100.
26. Hamper, B., A. L. Notkins, M. Mage, and M. A. Keehn. 1968. Heterogeneity in the properties of 7s and 9s rabbit neutralizing antibodies to herpes simplex virus. J. Immunol. 100:586-591.
27. Harris, S. L., I. Frank, A. Yee, G. H. Cohen, R. J. Eisenberg, and H. M. Friedman. 1990. Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization. J. Infect. Dis. 162:331-337.
28. Highlander, S. L., W. Cai, S. Person, M. Levine, and J. C. Glorioso. 1988. Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration. J. Virol. 62:1881-1888.
29. Hutchinson, L., H. Browne, V. Wargent, N. Davis-Poynter, S. Primorac, K. Goldsmith, A. C. Minson, and D. C. Johnson. 1992. A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH. J. Virol. 66:2240-2250.
30. Hutchinson, L., K. Goldsmith, D. Snoddy, H. Ghosh, F. L. Graham, and D. C. Johnson. 1992. Identification and characterization of a novel herpes simplex virus glycoprotein, gK, involved in cell fusion. J. Virol. 66:5603-5609.
31. Johnson, D. C., and V. Feenstra. 1987. Identification of a novel herpes simplex virus type 1-induced glycoprotein which complexes with gE and binds immunoglobulin. J. Virol. 61:2208-2216.
32. Kohl, S. 1991. Role of antibody-dependent cellular cytotoxicity in defense against herpes simplex virus infections. Rev. Infect. Dis. 13:108-114.
33. Kolaitis, G., M. Doymaz, and B. T. Rouse. 1990. Demonstration of MHC class H-restricted cytotoxic T lymphocytes in mice against herpes simplex virus. Immunology 71:101-106.
34. Lawman, M. J. P., R. J. Courtney, R. Eberle, P. A. Schaffer, M. K. O'Hara, and B. T. Rouse. 1980. Cell-mediated immunity to herpes simplex virus: specificity of cytotoxic T cells. Infect. Immun. 30:451-461.
35. Lawman, M. J. P., B. T. Rouse, R. J. Courtney, and R. D. Walker. 1980. Cell mediated immunity against herpes simplex induction of cytotoxic T lymphocytes. Infect. Immun. 27:133-139.
36. Little, S. P., J. T. Jofre, R. J. Courtney, and P. A. Schaffer. 1981. A virion associated glycoprotein essential for infectivity of herpes simplex virus type 1. Virology 115:149-160.
37. Martin, S., B. Moss, P. W. Berman, L. A. Laskey, and B. T. Rouse. 1987. Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T cells. J. Virol. 61:726-734.
38. McGeoch, D. J., M. B. Dalrymple, A. J. Davison, A. Dolan, M. C. Frame, D. McNab, L. J. Perry, J. E. Scott, and P. Taylor. 1988. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol. 69:1531-1574.
39. McNearney, T. A., C. Odell, M. Holers, P. G. Spear, and J. P. Atkinson. 1987. Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity. J. Exp. Med. 166:1525-1535.
40. Minson, A. C., T. C. Hodgman, P. Digard, D. C. Hancock, S. E. Bell, and E. A. Buckmaster. 1986. An analysis of the biological properties of monoclonal antibodies against glycoprotein D of herpes simplex virus and identification of amino acid substitutions that confer resistance to neutralisation. J. Gen. Virol. 67:1001-1013.
41. Nagafuchi, S., I. Hayashida, K. Higa, T. Wada, and R. Mori. 1982. Role of Lyt-1 positive immune T cells in recovery from herpes simplex virus infection in mice. Microbiol. Immunol. 26:359-362.
42. Nash, A. A., H. J. Field, and R. Quartey-Papafio. 1980. Cell-mediated immunity in herpes simplex virus infected mice: induction, characterization and antiviral effects of delayed type hypersensitivity. J. Gen. Virol. 48:351-357.
43. Nash, A. A., and P. G. H. Cell. 1980. Cell-mediated immunity in herpes simplex virus infected mice: suppression of delayed hypersensitivity by an antigen-specific B lymphocyte. J. Gen. Virol. 48:359-364.
44. Norrild, B. 1985. Humoral response to herpes simplex virus infections, p. 69-86. In B. Roizman and C. Lopez (ed.), The herpesviruses. Plenum Press, New York.
45. Sarmiento, M., M. Haffey, and P. G. Spear. 1979. Membrane proteins specified by herpes simplex virus. III. Role of glycoprotein VP7 (B2) in virion infectivity. J. Virol. 29:1149-1158.
46. Seidel-Dugan, C., M. Ponce de Leon, H. M. Friedman, L. F. Fries, M. M. Frank, G. H. Cohen, and R. J. Eisenberg. 1988. C3b receptor activity on transfected cells expressing glycoprotein C of herpes simplex virus types 1 and 2. J. Virol. 62:4027-4036.
47. Smiley, M. L., and H. M. Friedman. 1985. Binding of complement component C3b to glycoprotein C is modulated by sialic acid on herpes simplex virus type 1-infected cells. J. Virol. 55:857-861.
48. Spear, P. G. 1985. Glycoproteins specified by herpes simplex virus, p. 315-356. In B. Roizman and C. Lopez (ed.), The herpesviruses. Plenum Press, New York.
49. Staats, H. F., and R. N. Lausch. 1993. Cytokine expression in vivo during murine herpetic stromal keratitis. J. Immunol. 151:227-283.
50. Watson, R. J., J. H. Weis, J. S. Salstrom, and L. W. Enquist. 1982. Herpes simplex virus type 1 glycoprotein D gene: nucleotide sequence and expression in Escherichia coli. Science 218:381-384.
51. Wechsler, S. L., A. B. Nesburn, R. J. Watson, S. M. Slanina, and H. Ghiasi. 1988. Fine mapping of the latency-related gene of herpes simplex virus type 1: alternative splicing produces distinct latency-related RNAs containing open reading frames. J. Virol. 62:4051-4058.
52. Williams, R. C., E. Kievit, N. Tsuchiya, C. Malone, and L. Hutt-Fletcher. 1992. Differential mapping of Fcgamma-binding and monoclonal antibody-reactive epitopes on gE, the Fcgamma-binding glycoprotein of herpes simplex virus type-1. J. Immunol. 149:2415-2427.